Animalogy

Specific expertise in Consumer / Healthcare / Animal Nutrition On behalf of funds, I act as CEO/COO/Operating Partner/Board Member Key accountabilities : • 2025 - International Expansion of Petfood and Equine company (B2C + B2B via private label) under LBO for French Private Equity -> go-to-market strategy clarification + local management review + 1 major market opened with new distribution partner • 2025 - Business review of DTC Cat Petfood UK for mid-large US Private Equity -> Value Creation Plan support with minority share investment • 2025 - Pre-Acquisition business review of Berlin-based Healthy Snacking business for Luxembourg Family Office -> acting as investment committee's guest member resulting in minority share investment • 2024 - Target acquisition screening in the Fresh Petfood space across France/Belgium/DACH for French smallcap Private Equity -> no investment decided • 2024 - Portfolio review and Buy-Out options (sell-side) for the pet supplements leader in Brazil with M&A boutique. • 2023 - Post-Acquisition management & business reviews of DTC Dog Petfood on behalf of two shareholders (French PE + FO)-> management team reshuffle (one cofounder fired)+ complete operating model reviewed • 2023 - Scale-up for German Healthy Snack company on behalf of Paris-based Private Equity specialized in Consumer-> Where to Play/How to win approach for French market + staffing reco • 2022 - Review of market opportunities in Petcare for large Paris-based Family Office specialized in Healthcare & Education • 2021 - Business Analysis of DTC Petfood for French PE -> development model reviewed with new growth levers • 2020 - Due Diligence of DTC Petfood leader in France for major international PE firm (1st round) and UK Family Office (2nd round)